Positive Language for Anesthesia Pain Reduction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether positive language describing an epidural can reduce pain during the procedure. Participants will be divided into two groups: one will hear a negative description (Negative Connotation Language), and the other will hear a positive description (Positive Connotation Language) of the procedure. The goal is to determine if the explanation impacts pain perception. The trial seeks pregnant individuals requesting an epidural for the first time, without previous epidurals or certain medical conditions. As an unphased trial, this study offers a unique opportunity to contribute to understanding how language affects pain management during childbirth.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on chronic opioids, you would not be eligible to participate.
What prior data suggests that this protocol is safe for participants?
Research has shown that using positive words during medical procedures can help reduce pain perception. This involves using kind or reassuring language. Studies have found that such words can lessen the intensity of pain. While specific safety information about using positive language in medical settings is not available, changing the words used is unlikely to cause harm.
It is important to note that this trial focuses on language, not a physical treatment or drug. Therefore, there is no need to worry about side effects typically associated with medication or other medical treatments.12345Why are researchers excited about this trial?
Researchers are excited about the Positive Language for Anesthesia Pain Reduction trial because it explores a unique approach to pain management. Unlike traditional methods that rely on medications like opioids or NSAIDs to reduce pain, this trial investigates how the type of language used by medical professionals can influence a patient's pain perception. The study compares the effects of negative connotation language (Nocebo Group) with positive connotation language (Positive Connotation Group) during anesthesia. This innovative approach could offer a non-drug alternative to managing pain, potentially reducing reliance on medications and their associated side effects.
What evidence suggests that this trial's treatments could be effective for reducing pain during an epidural?
Research has shown that using positive language during medical procedures can reduce pain and anxiety. In this trial, participants in the Positive Connotation Group will receive the experimental treatment involving positive language. Speaking kindly or offering reassurance can lessen patients' pain. Conversely, participants in the Nocebo Group will receive the control treatment, which involves negative connotation language, as negative words can worsen discomfort. Studies suggest that doctors and nurses can relieve pain by providing positive messages that alter patients' expectations. Thus, using positive words can make the experience less painful for patients.12367
Who Is on the Research Team?
Aaron Berg, MD
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for pregnant individuals who are requesting an epidural for the first time and can speak English. It's not suitable for those with a history of opioid abuse, previous epidurals or lumbar spine surgery, a BMI over 40 kg/m^2, or chronic pain patients on opioids.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the 'Poke and a burn' or 'numbing medication' script during epidural placement
Follow-up
Participants are monitored for satisfaction and pain score after the epidural procedure
What Are the Treatments Tested in This Trial?
Interventions
- Negative Connotation Language
- Positive Connotation Language
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor